Table II.

Adjusted Cumulative Incidence and Standardized Incidence Ratio of psoriatic patients treated with systemic therapies and compared with equivalent definition in the general population of Spain

	Observed cases in Biobadaderm	Expected cases	Adjusted cumulative incidence 9 5CI% (per 100,000 patient-years)	SIR 95 CI%
All PCR-confirmed cases vs Spanish-confirmed cases	21	13.3	959.5 (593-1469)	1.58 (0.98-2.41)
PCR Hospitalized cases vs Spanish hospitalized cases	8	5.2	349.8 (149.4-692.6)	1.55 (0.67-3.06)
PCR ICU cases vs Spanish ICU cases	1	0.6	33.5 (0-192)	1.78 (0.05-9.93)
PCR death cases vs Spanish death cases	1	0.7	69.5 (0-398.3)	1.38 (0.03-7.66)